Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparative Study of Efficacy and Safety of Three Intra Articular Injections of V0220 Versus Hyalgan174; in Patients Suffering From Symptomatic Knee Osteoarthritis. A Multinational Multicentric, Randomised, Double-blind, Parallel-group Study.

Next Previous
X
Search
Trial Profile

Comparative Study of Efficacy and Safety of Three Intra Articular Injections of V0220 Versus Hyalgan174; in Patients Suffering From Symptomatic Knee Osteoarthritis. A Multinational Multicentric, Randomised, Double-blind, Parallel-group Study.

Status: Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Chondroitin sulfate; Hyaluronic acid
  • Indications Osteoarthritis
  • Focus Registrational; Therapeutic Use
  • Acronyms VESTA
  • Sponsors Pierre Fabre

    • Most Recent Events

    • 21 Feb 2013 Biomarkers information updated
    • 20 Feb 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 29 Nov 2012 Planned initiation date changed from 1 Oct 2012 to 1 Feb 2013 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top